AI model GPT-4 exceeds unspecialized doctors’ ability to assess eye problems

The clinical knowledge and reasoning skills of GPT-4 are approaching the level of specialist eye doctors, a study led by the University of Cambridge has found.

Former Nurse Sees Raft of New Charges in Murder Investigation

A former Pennsylvania nurse already charged with killing two patients confessed last week to attempting to kill another 19, according to authorities. In late May,

November 7, 2023

Forbion raises €2.1B for two new biotech funds after series of company exits

Sign up for free to read a limited number of articles each month. Pick what newsletters get delivered to your inbox each week. Biopharma ENDPOINTS

October 16, 2024

FDA approves EpiPen alternative, a nasal spray for anaphylaxis

On Friday, the Food and Drug Administration approved the first needle-free treatment for adults and kids with severe allergic reactions. The approval introduces a competitor

August 9, 2024

Supercharge Your Portfolio with Future Health Stocks!

Join us for Profitable Insights & Expert Tips!

With expert analysis, comprehensive market coverage, and actionable insights, our newsletter equips you with the knowledge & tools necessary to make informed decisions & maximize your potential returns in the dynamic world of future health stocks.